What are the common and serious adverse effects of GLP1 receptor agonists (e.g., exenatide, liraglutide, semaglutide, dulaglutide, tirzepatide) and how should they be managed?
Barlowe TS, Anderson C, Sandler RS, et al
GLP-1 medications slow down the movement of food through the digestive tract, which helps control blood sugar spikes after meals
Drauch, V
Morin says prior authorization has become a central lever for controlling drug costs
doi: 10.3389/fphar.2020.01270 Received 08 May 2020 Accepted 31 July 2020 Published 14 August 2020 Volume 11 - 2020 Edited by Bart Ellenbroek, Victoria University of Wellington, New Zealand Reviewed by Victor Gault, Ulster University, United Kingdom